Galenical formulations of aliskiren and hydrochlorothiazide

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/20 (2006.01) A61K 31/165 (2006.01) A61K 31/549 (2006.01)

Patent

CA 2654872

The present invention relates to a solid oral dosage form comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, a therapeutically effective amount of HCTZ and a hydrophilic filler selected from the group a carbohydrate or combinations thereof, e.g. sugars, sugar alcohols and starches or combinations of these.

La présente invention concerne une forme pharmaceutique solide destinée à l'administration par voie orale comprenant une quantité, efficace d'un point de vue thérapeutique, d'aliskirène ou d'un sel de celui-ci acceptable sur le plan pharmaceutique, une quantité, efficace d'un point de vue thérapeutique, de HCTZ et une charge hydrophile sélectionnée dans le groupe constitué des glucides ou des associations de ceux-ci, par exemple les sucres, les polyols et les amidons ou les associations de ceux-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Galenical formulations of aliskiren and hydrochlorothiazide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galenical formulations of aliskiren and hydrochlorothiazide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenical formulations of aliskiren and hydrochlorothiazide will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1762362

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.